1,2,3,4-TETRAHYDRO-8,11-DIHYDROXY-4-(2-HYDROXYETHYL)-6-((2-((2-HYDROXYETHYL)AMINO)ETHYL)AMINO)NAPHTHO(2,3-F)QUINOXALINE-7,12-DIONE
UNII EQ3TEW33AQ
Substance Identification & Data
This profile provides standardized clinical and technical data for 1,2,3,4-tetrahydro-8,11-dihydroxy-4-(2-hydroxyethyl)-6-((2-((2-hydroxyethyl)amino)ethyl)amino)naphtho(2,3-f)quinoxaline-7,12-dione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) EQ3TEW33AQ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 137132-70-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H26N4O6 GJMHXLAWJIOZMT-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1,2,3,4-tetrahydro-8,11-dihydroxy-4-(2-hydroxyethyl)-6-((2-((2-hydroxyethyl)amino)ethyl)amino)naphtho(2,3-f)quinoxaline-7,12-dione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.